JPMA Official Hails MHLW Discussions on Use of “Specified Clinical Research” Data in Application Dossiers

September 10, 2018
(from left) Dr Fujiwara, Mr Hakuno, Mr Kunitada A senior official of the Japan Pharmaceutical Manufacturers Association (JPMA) on September 7 welcomed news that the health ministry has started discussions on ways to harness data from so-called “specified clinical research...read more